Variant position: 101 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 432 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human ASYIEKVRFLEQQNKALAAE LNQLRAKEPTKLADVYQAELR
Mouse ASYIEKVRFLEQQNKALAAE LNQLRAKEPTKLADVYQAELR
Rat ASYIEKVRFLEQQNKALAAE LNQLRAKEPTKLADVYQAELR
Bovine ASYIEKVRFLEQQNKALAAE LNQLRAKEPTKLADVYQAELR
Zebrafish ASYIEKVRFLEQQNKMLVAE LNQLRGKEPSRLGDIYQEELR
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 432 Glial fibrillary acidic protein
69 – 377 IF rod
73 – 104 Coil 1A
82 – 82 Phosphoserine
110 – 110 Phosphothreonine
Novel GFAP mutation in patient with adult-onset Alexander disease presenting with spastic ataxia.
Kaneko H.; Hirose M.; Katada S.; Takahashi T.; Naruse S.; Tsuchiya M.; Yoshida T.; Nakagawa M.; Onodera O.; Nishizawa M.; Ikeuchi T.;
Mov. Disord. 24:1393-1395(2009)
Cited for: VARIANT ALXDRD PRO-101;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.